Tracking gut bacteria changes and nausea during chemo
Part of Cancer, Digestive system clinical trials.
This study looks at how changes in the gut “microbiome” (your gut bacteria) relate to fatigue and chemotherapy-induced nausea in people with early-stage breast cancer. It may help doctors better understand why nausea and fatigue happen and how to predict or manage them during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer and plan to start chemotherapy soon
- You are at least 20 years old
- Your last chemotherapy (if you had any) was more than 3 years ago
- Your planned chemotherapy is considered moderate to highly likely to cause nausea
- You are not currently being treated with antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your diet and the natural bacteria in your gut (microbiome) may affect how well chemotherapy and immunotherapy work for early-stage triple-negative breast cancer. By participating, you may help doctors understand if certain gut bacteria can improve treatment outcomes.
This study looks at how changing your diet during chemotherapy affects side effects and your body's energy use. It involves providing stool samples to study gut bacteria.
This trial tests whether adding acupuncture to standard care can help manage nausea, vomiting, and other stomach symptoms caused by chemotherapy in people with early-stage breast cancer. It is for those about to start their first round of strong chemo.
This study looks at why some people feel very tired during cancer treatment. Researchers will collect blood and stool samples to study how the body responds to chemotherapy and radiation.
This study looks at how chemotherapy or chemoradiotherapy changes the bacteria in your gut. It aims to understand if these changes can make bacteria resistant to antibiotics, which might help improve future cancer care.
This study looks at your gut “microbiome” (the bacteria in your intestines) while you receive high-dose chemotherapy and a stem cell transplant, or CAR-T cell therapy. Researchers hope to understand how these treatments affect the microbiome, which may relate to how well patients do.
Hear when a new Early Stage Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.